Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Venue 22
About the venue
Rooms
Call for abstracts
Programme 22
Tracks 22
Speakers 22
Side events 22
Subscribe
days
hours
minutes
seconds
Oral presentation session
Sessions
PDF version
Wednesday, 23 November
10:50
Advances in toxicology
10:50
to
12:20
Central square 2 (C2)
Oral presentation session
Commonalities across addictions
10:50
to
12:20
Insights zone 2 (I2)
Oral presentation session
COVID-19 implications for services and responses
10:50
to
12:20
Central square 3 (C3)
Oral presentation session
Drug treatment
10:50
to
12:20
Knowledge market 3 (K3)
Oral presentation session
Gambling Research
10:50
to
12:20
Insights zone 3 (I3)
Oral presentation session
13:20
e-/m-health interventions for substance use disorders
13:20
to
14:50
Central square 3 (C3)
Oral presentation session
Gambling epidemiology and new trends
13:20
to
14:50
Insights zone 3 (I3)
Oral presentation session
Hepatitis C epidemiology and prevention
13:20
to
14:50
Knowledge market 3 (K3)
Oral presentation session
15:00
Alcohol use and AUD during COVID-19 pandemic
15:00
to
16:30
Central square 1 (C1)
Oral presentation session
Estimating harm
15:00
to
16:30
Central square 3 (C3)
Oral presentation session
Estimating prevalence
15:00
to
16:30
Knowledge market 4 (K4)
Oral presentation session
Injecting-related infections and drug surveillance
15:00
to
16:30
Knowledge market 3 (K3)
Oral presentation session
16:50
Alcohol use disorder treatment and its epidemiology
16:50
to
18:20
Central square 1 (C1)
Oral presentation session
Drugs and community
16:50
to
18:20
Insights zone 2 (I2)
Oral presentation session
EU4MD Treatment facility survey
16:50
to
18:20
Networking zone 2 (N2)
Oral presentation session
Focusing on gender issues
16:50
to
18:20
Central square 3 (C3)
Oral presentation session
Thursday, 24 November
09:00
Contemporary Issues
09:00
to
10:30
Central square 2 (C2)
Oral presentation session
10:50
Alcohol policies
10:50
to
12:20
Central square 1 (C1)
Oral presentation session
Neurology and neuropsychology
10:50
to
12:20
Central square 3 (C3)
Oral presentation session
Online and social identities
10:50
to
12:20
Insights zone 2 (I2)
Oral presentation session
Practitioners informing practice
10:50
to
12:20
Knowledge market 3 (K3)
Oral presentation session
Problematic internet and videogame use
10:50
to
12:20
Insights zone 3 (I3)
Oral presentation session
Substance use and trauma
10:50
to
12:20
Knowledge market 2 (K2)
Oral presentation session
13:20
Childhood risk factors in substance use and mental health
13:20
to
14:50
Knowledge market 2 (K2)
Oral presentation session
Hepatitis C testing and treatment
13:20
to
14:50
Knowledge market 3 (K3)
Oral presentation session
New Psychoactive Substances
13:20
to
14:50
Insights zone 4 (I4)
Oral presentation session
Novel approaches of alcohol use disorder
13:20
to
14:50
Central square 1 (C1)
Oral presentation session
Smoking and e-cigarettes
13:20
to
14:50
Central square 3 (C3)
Oral presentation session
Understanding problematic gambling
13:20
to
14:50
Insights zone 3 (I3)
Oral presentation session
15:00
Client-centered approaches
15:00
to
16:30
Central square 3 (C3)
Oral presentation session
Models to improve the health of people who inject drugs
15:00
to
16:30
Knowledge market 3 (K3)
Oral presentation session
Preventions interventions
15:00
to
16:30
Insights zone 2 (I2)
Oral presentation session
Substance use and mental health during COVID-19
15:00
to
16:30
Knowledge market 2 (K2)
Oral presentation session
16:50
Innovative approaches to tackling the drug overdoses
16:50
to
18:20
Knowledge market 1 (K1)
Oral presentation session
Insights from treatment I
16:50
to
18:20
Central square 3 (C3)
Oral presentation session
New frontiers to regulating cannabis for public health and social justice
16:50
to
18:20
Insights zone 2 (I2)
Oral presentation session
Trajectories of cannabis use during periods of policy change
16:50
to
18:20
Central square 2 (C2)
Oral presentation session
Young people, substance use and prevention
16:50
to
18:20
Knowledge market 3 (K3)
Oral presentation session
Friday, 25 November
09:00
Insights from treatment II
09:00
to
10:30
Central square 2 (C2)
Oral presentation session
10:50
Gambling, policies and interventions
10:50
to
12:20
Insights zone 3 (I3)
Oral presentation session
Harm reduction or prevention?
10:50
to
12:20
Insights zone 2 (I2)
Oral presentation session
Language values and theory in drugs policy reform
10:50
to
12:20
Knowledge market 1 (K1)
Oral presentation session
Mortality among people who use drugs
10:50
to
12:20
Knowledge market 3 (K3)
Oral presentation session
Recreational drug use and risk
10:50
to
12:20
Central square 3 (C3)
Oral presentation session
Substance use and prison
10:50
to
12:20
Central square 1 (C1)
Oral presentation session
Substance use and sexual behaviours
10:50
to
12:20
Knowledge market 4 (K4)
Oral presentation session
13:20
Challenging issues for drug research
13:20
to
14:50
Central square 1 (C1)
Oral presentation session
Changes and trends in how people are buying drugs
13:20
to
14:50
Insights zone 4 (I4)
Oral presentation session
Overdose prevention
13:20
to
14:50
Knowledge market 3 (K3)
Oral presentation session
Substance use, mental health risk and suicide
13:20
to
14:50
Knowledge market 2 (K2)
Oral presentation session
Using innovative data or methods to assess drug markets and drug policy impacts
13:20
to
14:50
Knowledge market 1 (K1)
Oral presentation session
Working with the most vulnerable
13:20
to
14:50
Central square 3 (C3)
Oral presentation session
PDF version PDF version PDF version